Sun Pharmaceuticals has won new support in its year-long tussle to buy Israeli drugmaker Taro Pharmaceuticals--in the form of backing from major Taro shareholder Templeton Asset Management. Report [1]
Links:
[1] http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/Templeton-backs-Sun-in-Taro-bid/articleshow/5289615.cms